NG
BIIB icon

NatWest Group’s Biogen BIIB Stock Holding History

NatWest Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-653
Closed -$207K – 63
2020
Q1 		$207K Buy
+653
New +$198K 0.06% 80
2018
Q4 		– Sell
-692
Closed -$244K – 77
2018
Q3 		$244K Sell
692
-160
-19% -$55.1K 0.04% 72
2018
Q2 		$247K Hold
852
– – 0.05% 74
2018
Q1 		$233K Sell
852
-80
-9% -$24.8K 0.05% 78
2017
Q4 		$297K Sell
932
-95
-9% -$30.5K 0.07% 69
2017
Q3 		$322K Sell
1,027
-10
-1% -$2.96K 0.08% 85
2017
Q2 		$282K Sell
1,037
-100
-9% -$26.4K 0.07% 88
2017
Q1 		$311K Sell
1,137
-1,710
-60% -$483K 0.07% 91
2016
Q4 		$807K Sell
2,847
-740
-21% -$219K 0.21% 60
2016
Q3 		$1.12M Sell
3,587
-464
-11% -$137K 0.26% 59
2016
Q2 		$980K Sell
4,051
-8,524
-68% -$2.25M 0.25% 62
2016
Q1 		$3.27M Sell
12,575
-3,054
-20% -$807K 0.73% 34
2015
Q4 		$4.79M Sell
15,629
-8,741
-36% -$2.51M 0.96% 34
2015
Q3 		$7.11M Buy
24,370
+1,382
+6% +$456K 0.16% 84
2015
Q2 		$9.29M Buy
22,988
+2,827
+14% +$1.13M 0.12% 68
2015
Q1 		$8.51M Buy
20,161
+3,250
+19% +$1.28M 0.11% 79
2014
Q4 		$5.74M Buy
16,911
+5,598
+49% +$1.81M 0.05% 107
2014
Q3 		$3.74M Buy
11,313
+7
+0.1% +$2.31K 0.03% 144
2014
Q2 		$3.56M Buy
11,306
+2,873
+34% +$865K 0.15% 147
2014
Q1 		$2.58M Sell
8,433
-18,752
-69% -$5.95M 0.11% 154
2013
Q4 		$7.6M Buy
27,185
+5,753
+27% +$1.49M 0.19% 119
2013
Q3 		$5.16M Sell
21,432
-35,929
-63% -$8.04M 0.15% 144
2013
Q2 		$12.3M Buy
+57,361
New +$12.3M 0.18% 101

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NatWest Group's BIIB Position: Q2 2020 in Review

NatWest Group sold out of Biogen (BIIB) in Q2 2020, closing a stake of 653 shares — an estimated $207K sold.

NatWest Group first reported a position in BIIB in Q2 2013 and held it in 23 quarters. The position peaked at $12.3M in Q2 2013. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • NatWest Group reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • NatWest Group sold 653 Biogen shares in Q2 2020, an estimated $207K.
  • NatWest Group first reported a position in Biogen in Q2 2013 and held it in 23 quarters.
  • NatWest Group's Biogen position peaked at $12.3M in Q2 2013.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on NatWest Group's 13F filing for Q2 2020, filed 16 Jul 2020.